Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark C Walters

Showing results (51-60 of 86) with videos related to

Pageof 9
Sort By:
Blood Advances|September 28, 2021
American Society of Hematology 2021 guidelines for sickle cell disease: stem cell transplantationJulie Kanter, Robert I Liem, Françoise Bernaudin, et al.
Blood|May 23, 2013
Outcome of patients with hemoglobinopathies given either cord blood or bone marrow transplantation from an HLA-identical siblingFranco Locatelli, Nabil Kabbara, Annalisa Ruggeri, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 25, 2025
Nonclinical evaluation of renizgamglogene autogedtemcel for SCD and TDTEugenio Marco, Patricia Sousa, Tusneem Janoudi, et al.
Bone Marrow Transplantation|June 15, 2018
The safety and efficacy of clofarabine in combination with high-dose cytarabine and total body irradiation myeloablative conditioning and allogeneic stem cell transplantation in children, adolescents, and young adults (CAYA) with poor-risk acute leukemiaJessica Hochberg, Stacey Zahler, Mark B Geyer, et al.
Science Translational Medicine|October 14, 2016
Selection-free genome editing of the sickle mutation in human adult hematopoietic stem/progenitor cellsMark A DeWitt, Wendy Magis, Nicolas L Bray, et al.
Transplantation and Cellular Therapy|March 26, 2023
Access to Chimeric Antigen Receptor T Cell Clinical Trials in Underrepresented Populations: A Multicenter Cohort Study of Pediatric and Young Adult Acute Lymphobastic Leukemia PatientsAnurekha G Hall, Lena E Winestone, Erin M Sullivan, et al.
Blood|June 11, 2020
Risk score to predict event-free survival after hematopoietic cell transplant for sickle cell diseaseRuta Brazauskas, Graziana M Scigliuolo, Hai-Lin Wang, et al.
Biorxiv : the Preprint Server for Biology|April 27, 2026
Combinatorial base editing couples disease correction with lineage amplification in hematopoietic stem and progenitor cellsKun Jia, Eric Soupene, Roshani Sinha, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 21, 2012
Unrelated donor cord blood transplantation for children with severe sickle cell disease: results of one cohort from the phase II study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN)Naynesh R Kamani, Mark C Walters, Shelly Carter, et al.
Frontiers in Neurology|June 6, 2024
Neurocognitive outcome in children with sickle cell disease after myeloimmunoablative conditioning and haploidentical hematopoietic stem cell transplantation: a non-randomized clinical trialSuzanne Braniecki, Elliott Vichinsky, Mark C Walters, et al.
Pageof 9

Showing results (51-60 of 86) with videos related to

Sort By:
Pageof 9
Blood Advances|September 28, 2021
American Society of Hematology 2021 guidelines for sickle cell disease: stem cell transplantationJulie Kanter, Robert I Liem, Françoise Bernaudin, et al.
Blood|May 23, 2013
Outcome of patients with hemoglobinopathies given either cord blood or bone marrow transplantation from an HLA-identical siblingFranco Locatelli, Nabil Kabbara, Annalisa Ruggeri, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 25, 2025
Nonclinical evaluation of renizgamglogene autogedtemcel for SCD and TDTEugenio Marco, Patricia Sousa, Tusneem Janoudi, et al.
Bone Marrow Transplantation|June 15, 2018
The safety and efficacy of clofarabine in combination with high-dose cytarabine and total body irradiation myeloablative conditioning and allogeneic stem cell transplantation in children, adolescents, and young adults (CAYA) with poor-risk acute leukemiaJessica Hochberg, Stacey Zahler, Mark B Geyer, et al.
Science Translational Medicine|October 14, 2016
Selection-free genome editing of the sickle mutation in human adult hematopoietic stem/progenitor cellsMark A DeWitt, Wendy Magis, Nicolas L Bray, et al.
Transplantation and Cellular Therapy|March 26, 2023
Access to Chimeric Antigen Receptor T Cell Clinical Trials in Underrepresented Populations: A Multicenter Cohort Study of Pediatric and Young Adult Acute Lymphobastic Leukemia PatientsAnurekha G Hall, Lena E Winestone, Erin M Sullivan, et al.
Blood|June 11, 2020
Risk score to predict event-free survival after hematopoietic cell transplant for sickle cell diseaseRuta Brazauskas, Graziana M Scigliuolo, Hai-Lin Wang, et al.
Biorxiv : the Preprint Server for Biology|April 27, 2026
Combinatorial base editing couples disease correction with lineage amplification in hematopoietic stem and progenitor cellsKun Jia, Eric Soupene, Roshani Sinha, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 21, 2012
Unrelated donor cord blood transplantation for children with severe sickle cell disease: results of one cohort from the phase II study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN)Naynesh R Kamani, Mark C Walters, Shelly Carter, et al.
Frontiers in Neurology|June 6, 2024
Neurocognitive outcome in children with sickle cell disease after myeloimmunoablative conditioning and haploidentical hematopoietic stem cell transplantation: a non-randomized clinical trialSuzanne Braniecki, Elliott Vichinsky, Mark C Walters, et al.
Pageof 9